Beranda › Sklerosis Multipel › New York › New York City
Uji klinis Sklerosis Multipel di New York City, NY
17 studi untuk Sklerosis Multipel mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of the MIND Diet for Persons With Multiple Sclerosis
Menerima peserta
- Mount Sinai Hospital, New York
Vancomycin Study in Multiple Sclerosis (MS)
Menerima pesertaFase 1
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Menerima pesertaStudi observasional
- TG Therapeutics Investigational Trial Site, New York
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Menerima pesertaFase 1/2
- Mt. Sinai, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- NYU Langone Health, New York
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Menerima pesertaFase 1
- TG Therapeutics Investigational Trial Site, New York
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Menerima pesertaFase 1
- Research Site, New York
- Research Site, New York
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Menerima pesertaFase 2
- Mount Sinai School of Medicine, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
Menerima pesertaFase 2
- NYU Langone Health, New York
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mount Sinai Hospital, New York
Genes and Environment in Multiple Sclerosis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Columbia University Irving Center, New York
A Palliative Care Model Impact on Knowledge and Attitudes
Menerima peserta
- Judith Jaffe Multiple Sclerosis Center, New York
- Hunter College, New York
NYSCF Scientific Discovery Biobank
Menerima pesertaStudi observasional
- New York Stem Cell Foundation Research Institute, New York
Eccentric Exercise and Fatigue in Multiple Sclerosis
Menerima pesertaStudi observasional
- Hunter College, Physical Therapy Department, City University of New York, New York
Effect of Cooling on Balance Performance in Multiple Sclerosis
Menerima pesertaStudi observasional
- Hunter College, Physical Therapy Department, City University of New York, New York
Uji klinis Sklerosis Multipel di kota lain
- Chicago, IL15 studi
- Boston, MA14 studi
- Washington, DC13 studi
- Cleveland, OH9 studi
- St. Louis, MO8 studi
- Kansas City, KS8 studi
- Birmingham, AL8 studi
- San Francisco, CA8 studi
- Columbus, OH7 studi
- Aurora, CO7 studi
- Baltimore, MD7 studi
- Farmington Hills, MI6 studi
Studi lain di New York City
- Kanker Payudara134 studi
- Kanker Paru Non-Sel Kecil120 studi
- Kanker (semua jenis)110 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal77 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Kanker Pankreas60 studi
- Mieloma Multipel60 studi
- Kanker Endometrium52 studi
- Gagal Jantung51 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.